Ragweed allergy immunotherapy - Stallergenes Greer plc

Drug Profile

Ragweed allergy immunotherapy - Stallergenes Greer plc

Alternative Names: Ragweed pollen extract - Stallergenes Greer plc; Ragweed SLIT tablets - Stallergenes Greer plc; STAGR SAIL™ SLIT

Latest Information Update: 26 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Stallergenes SA
  • Developer Stallergenes Greer plc
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Seasonal allergic rhinitis

Most Recent Events

  • 30 Nov 2012 Clinical development is ongoing
  • 26 Oct 2010 Stallergenes completes a phase I trial in Seasonal allergic rhinitis in Hungary
  • 01 Jan 2009 Phase-I clinical trials in Seasonal allergic rhinitis in Hungary (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top